Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Immunology Communications is Scopus-indexed (Q4, CiteScore 1.9), DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2772-6134Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 184 / 234 | 21st | Q4 |
| Immunology | 198 / 243 | 18th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q4, CiteScore 1.9.
Clinical Immunology Communications is Q4 in Immunology and Allergy (rank 184 of 234) and Q4 in Immunology (rank 198 of 243), by CiteScore 2025.
Clinical Immunology Communications is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.9, quartile Q4, 21st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.287, quartile Q4, with an H-index of 7.
The publisher lists an article processing charge of about US$1,860 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical Immunology Communications is published by Elsevier Inc. Its ISSN is 2772-6134.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Clinical Immunology Communications has an h-index of 10 and a 2-year mean of 1.37 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q4. On 2-year citations it ranks #149 of 231 Scopus journals in Immunology and Allergy.
Clinical Immunology Communications published 25 papers in 2025; its busiest recent year was 2022 with 32. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2022–2026), authors are most often from United States (27.7%), Brazil (11%) and India (10.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.